Is There a Role for Neoadjuvant Targeted Therapy to Downsize Primary Tumors for Organ Sparing Strategies in Renal Cell Carcinoma?

por Bex, A., Kroon, B. K., de Bruijn, R.
Publicado 2012

Sunitinib and other targeted therapies for renal cell carcinoma

por Powles, T, Chowdhury, S, Jones, R, Mantle, M, Nathan, P, Bex, A, Lim, L, Hutson, T
Publicado 2011

Laparoscopic Sentinel Lymph Node Biopsy for Prostate Cancer: The Relevance of Locations Outside the Extended Dissection Area

por Meinhardt, W., van der Poel, H. G., Valdés Olmos, R. A., Bex, A., Brouwer, O. R., Horenblas, S.
Publicado 2012

Editorial Comment: Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients With Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib: The SURTIME Rando...

por Bex, A, Mulders, P, Jewett, M, Wagstaff, J, van Thienen, JV, Blank, CU, Zequi, Stênio de C.
Publicado 2020

Editorial Comment: Feasibility and safety of irreversible electroporation (IRE) in patients with small renal masses: Results of a prospective study

por Buijs, M, Zondervan, PJ, de Bruin, DM, van Lienden, KP, Bex, A, van Delden, OM, Zequi, Stênio de C.
Publicado 2020

Percutaneous Microwave Ablation of Histologically Proven T1 Renal Cell Carcinoma

por Aarts, B. M., Prevoo, W., Meier, M. A. J., Bex, A., Beets-Tan, R. G. H., Klompenhouwer, E. G., Gómez, F. M.
Publicado 2020

Interactive virtual 3D models of renal cancer patient anatomies alter partial nephrectomy surgical planning decisions and increase surgeon confidence compared to volume-rendered im...

por Hyde, E. R., Berger, L. U., Ramachandran, N., Hughes-Hallett, A., Pavithran, N. P., Tran, M. G. B., Ourselin, S., Bex, A., Mumtaz, F. H.
Publicado 2019

The safety and efficacy of sunitinib before planned nephrectomy in metastatic clear cell renal cancer

por Powles, T., Kayani, I., Blank, C., Chowdhury, S., Horenblas, S., Peters, J., Shamash, J., Sarwar, N., Boletti, K., Sadev, A., O'Brien, T., Berney, D., Beltran, L., Haanen, J., Bex, A.
Publicado 2011

Cryoablation and immunotherapy: an overview of evidence on its synergy

por Aarts, B. M., Klompenhouwer, E. G., Rice, S. L., Imani, F., Baetens, T., Bex, A., Horenblas, S., Kok, M., Haanen, J. B. A. G., Beets-Tan, R. G. H., Gómez, F. M.
Publicado 2019

Immunotherapy with concurrent subcutaneous GM-CSF, low-dose IL-2 and IFN-α in patients with progressive metastatic renal cell carcinoma

por Verra, N, Jansen, R, Groenewegen, G, Mallo, H, Kersten, M J, Bex, A, Vyth-Dreese, F A, Sein, J, van de Kasteele, W, Nooijen, W J, de Waal, M, Horenblas, S, de Gast, G C
Publicado 2003

Variation in the management of cT1 renal cancer by surgical hospital volume: A nationwide study

por Yildirim, H., Schuurman, M. S., Widdershoven, C. V., Lagerveld, B. W., van den Brink, L., Ruiter, A. E. C., Beerlage, H. P., van Moorselaar, R. J. A., Graafland, N. M., Bex, A., Aben, K. K. H., Zondervan, P. J.
Publicado 2023